Click here to see a replay of the National Coverage Determinations and Consent to Treatment: An Enterprise Risk webinar. This presentation will examine the enterprise risk management (ERM) exposures stemming from the “three wrongs” NCDs. The featured speaker will discuss the importance of consent to treatment as a key ERM tool, along with other strategies to mitigate liability and exposure to compliance risks.

Objectives:

  • To describe the “three wrongs” and the role of consent to treatment in the National Coverage Determinations from CMS
  • To discuss the liability, compliance, and financial impacts of the National Coverage Determinations
  • To examine practical enterprise risk management strategies to mitigate the potential losses involved in the “three wrongs” National Coverage Determinations.
  • To illustrate how ego, misguided altruism, and loophole exploitation cause C-Suite executives and clinicians to make decisions resulting in criminal prosecutions and jail time.

 

Your rating: None
November 27, 2012

MediBlog - A Resource for the MediRegs User Group.   MediBlog was designed to allow you the opportunity to communicate directly with MediRegs specialists as well as colleagues that work in your field of work.

Recent Comments / Archives

Additional Resources

Disclaimer | Privacy & Cookies | Securities Statement | © 2007-2012 CCH Incorporated or its affiliates. | RSS